Post-earnings recap
Reported
Tue, Apr 23, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Edwards Lifesciences reported a strong EPS performance, beating expectations by 5.68%. The stock reacted positively, increasing by 1.52%. However, without revenue figures or management commentary, the overall context of the earnings remains unclear.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.32 | N/A | +5.68% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.